Introduction The past two decades have been marked by three epidemics linked to
emerging coronaviruses. The COVID-19 pandemic highlighted the existence of neurological …

Objective We sought to review the literature on cerebrospinal fluid (CSF) testing in patients
with COVID-19 for evidence of viral neuroinvasion by SARS-CoV-2. Methods We performed …

Background and purpose Neurological complications of SARS‐CoV‐2 infection are noticed
among critically ill patients soon after disease onset. Information on delayed neurological …

Clinical evidence suggests the central nervous system is frequently impacted by SARS-CoV-
2 infection, either directly or indirectly, although the mechanisms are unclear. Pericytes are …

Background and purpose To assess neurological manifestations and health‐related quality
of life (QoL) 3 months after COVID‐19. Methods In this prospective, multicenter …

Emerging data indicate that neurological complications occur as a consequence of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The blood–brain barrier …

Immune-related manifestations are increasingly recognized conditions in patients with
COVID-19, with around 3,000 cases reported worldwide comprising more than 70 different …

INTRODUCTION: This paper improves the methodology of the first edition of the rapid living
systematic review started in April 2020, with the aim to gather and present the current …

In some patients, COVID-19 can trigger neurological symptoms with unclear pathogenesis.
Here we describe a microphysiological system integrating alveolus and blood–brain barrier …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the aetiologic agent of the
coronavirus disease 2019 (COVID-19), is now rapidly disseminating throughout the world …